With telehealth stakeholders gearing up to lobby lawmakers for additional telehealth legislation after the end of the public health emergency and subsequent 151-day extension of COVID-19 pandemic telehealth waivers, distinctions between telehealth fraud and telefraud are again coming to the forefront as lobbyists await telehealth fraud studies from the HHS Office of Inspector General. Although telehealth stakeholders are planning to use the fraud studies to prove telemedicine is no more prone to fraud than in-person services, OIG says it may...